These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 30850934)

  • 41. Sustained Delivery of GLP-1 Receptor Agonists from Injectable Biomimetic Hydrogels Improves Treatment of Diabetes.
    d'Aquino AI; Maikawa CL; Nguyen LT; Lu K; Hall IA; Jons CK; Kasse CM; Yan J; Prossnitz AN; Chang E; Baker SW; Hovgaard L; Steensgaard DB; Andersen HB; Simonsen L; Appel EA
    bioRxiv; 2023 Jul; ():. PubMed ID: 36778223
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pen devices to improve patient adherence with insulin therapy in type 2 diabetes.
    Goldstein HH
    Postgrad Med; 2008 Sep; 120(3):172-9. PubMed ID: 18824835
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment adherence and the contemporary approach to treating type 2 diabetes mellitus.
    Kolars B; Minakovic I; Grabovac B; Zivanovic D; Mijatovic Jovin V
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2024 Jun; 168(2):97-104. PubMed ID: 38511473
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Medication adherence: a challenge for patients with postmenopausal osteoporosis and other chronic illnesses.
    Gold DT
    J Manag Care Pharm; 2006 Jul; 12(6 Suppl A):S20-5; quiz S26-8. PubMed ID: 17269854
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study.
    Sahota O; Narayanasamy M; Bastounis A; Paskins Z; Bishop S; Langley T; Gittoes N; Davis S; Baily A; Holmes M; Leonardi-Bee J
    Health Technol Assess; 2024 Apr; 28(21):1-169. PubMed ID: 38634483
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What can we learn from patient-reported outcomes of insulin pen devices?
    Anderson BJ; Redondo MJ
    J Diabetes Sci Technol; 2011 Nov; 5(6):1563-71. PubMed ID: 22226279
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A retrospective study of persistence, adherence, and health economic outcomes of fixed-dose combination vs. loose-dose combination of oral anti-diabetes drugs.
    Lokhandwala T; Smith N; Sternhufvud C; Sörstadius E; Lee WC; Mukherjee J
    J Med Econ; 2016; 19(3):203-12. PubMed ID: 26473990
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adherence With Oral Anticancer Therapies: Clinical Trial vs Real-world Experiences With a Focus on Prostate Cancer.
    Higano CS; Hafron J
    J Urol; 2023 Mar; 209(3):485-493. PubMed ID: 36472138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effects of patient out-of-pocket costs for insulin on medication adherence and health care utilization in patients with commercial insurance; 2007-2018.
    McAdam-Marx C; Ruiz-Negron N; Sullivan JM; Tucker JM
    J Manag Care Spec Pharm; 2022 May; 28(5):494-506. PubMed ID: 35392659
    [No Abstract]   [Full Text] [Related]  

  • 50. Qualitative Analysis of Factors Influencing Patient Persistence and Adherence to Prescribed Overactive Bladder Medication in UK Primary Care.
    Ali M; Grogan S; Powell S; Staniford L; Nazir J; Landeira M; Covernton PJO; Jaggi A; Fatoye F; Holt M
    Adv Ther; 2019 Nov; 36(11):3110-3122. PubMed ID: 31559603
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Greater persistence and adherence to basal insulin therapy is associated with lower healthcare utilization and medical costs in patients with type 2 diabetes: a retrospective database analysis.
    Aroda VR; Nielsen N; Mangla KK; Multani J; Divino V; Namvar T; Rajpura J
    BMJ Open Diabetes Res Care; 2024 Mar; 12(2):. PubMed ID: 38442988
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Socio-economic, demographic, and clinical correlates of poor glycaemic control within insulin regimens among children with Type 1 diabetes: the SEARCH for Diabetes in Youth  Study.
    Snyder LL; Stafford JM; Dabelea D; Divers J; Imperatore G; Law J; Lawrence JM; Pihoker C; Mayer-Davis EJ
    Diabet Med; 2019 Aug; 36(8):1028-1036. PubMed ID: 31050009
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A medication adherence and persistence comparison of hypertensive patients treated with single-, double- and triple-pill combination therapy.
    Xie L; Frech-Tamas F; Marrett E; Baser O
    Curr Med Res Opin; 2014 Dec; 30(12):2415-22. PubMed ID: 25222764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Impact of financial medication assistance on medication adherence: a systematic review.
    Hung A; Blalock DV; Miller J; McDermott J; Wessler H; Oakes MM; Reed SD; Bosworth HB; Zullig LL
    J Manag Care Spec Pharm; 2021 Jul; 27(7):924-935. PubMed ID: 34185554
    [No Abstract]   [Full Text] [Related]  

  • 55. Real-World Adherence and Persistence to Oral Disease-Modifying Therapies in Multiple Sclerosis Patients Over 1 Year.
    Johnson KM; Zhou H; Lin F; Ko JJ; Herrera V
    J Manag Care Spec Pharm; 2017 Aug; 23(8):844-852. PubMed ID: 28737986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adherence with pharmacotherapy for type 2 diabetes: a retrospective cohort study of adults with employer-sponsored health insurance.
    Hertz RP; Unger AN; Lustik MB
    Clin Ther; 2005 Jul; 27(7):1064-73. PubMed ID: 16154485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Barriers to effective insulin treatment: the persistence of poor glycemic control in type 2 diabetes.
    Ross SA; Tildesley HD; Ashkenas J
    Curr Med Res Opin; 2011 Nov; 27 Suppl 3():13-20. PubMed ID: 21942467
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A 'Real-World' Analysis of Persistence on and Adherence to Glipizide GITS, Glipizide IR and Glibenclamide in Managed Care among Patients with Type 2 Diabetes Mellitus.
    Hurley CR; Mishra A; Cantor SE; Nelson M; Walker AM
    Clin Drug Investig; 2002 Sep; 22(9):575-584. PubMed ID: 29492851
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Impact of single-pill combinations versus free-equivalent combinations on adherence and persistence in patients with hypertension and dyslipidemia: a systematic literature review and meta-analysis.
    Kengne AP; Brière JB; Le Nouveau P; Kodjamanova P; Atanasov P; Kochoedo M; Irfan O; Khan ZM
    Expert Rev Pharmacoecon Outcomes Res; 2024 Sep; 24(7):817-827. PubMed ID: 38088763
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.